PATH lays out recommendations for the US Administration and Congress to accelerate progress toward a malaria-free world. By fully funding malaria programs, intensifying support for research and development, and leveraging US influence globally, the United States can take a decisive step toward eradicating malaria and a healthier future for all.

Publication date: June 2017

Region: North America and Europe

As malaria programs move closer to achieving elimination, more sensitive point-of-care diagnostic tests are needed to detect the final parasite reservoirs. PATH and collaborators have developed a highly sensitive diagnostic test for Plasmodium falciparum malaria to use in the surveillance and mass screen-and-treat programs critical for malaria elimination.

Publication date: April 2017

Region: Global

The PATH Malaria Vaccine Initiative (MVI) is a vaccine development program of PATH. This fact sheet provides an overview of MVI's history, mission, vision, and work.

Publication date: February 2017

Region: Global

This brochure outlines PATH's work in Senegal. It describes our approach and outlines key areas of focus, including malaria elimination, strengthening health systems, responding to emerging health threats, improving reproductive health, and combatting noncommunicable diseases.

Publication date: January 2017

Region: Africa

Part of series: Country brochures

This four-page brochure describes PATH’s work in Zambia to improve health and save lives through innovation, data-driven decision-making, and collaboration. Featured areas of focus include malaria, health information systems, nutrition, and advocacy to improve policies and resource allocations. The brochure includes a map showing project locations.

Publication date: January 2017

Region: Africa

Part of series: Country brochures

This website about PATH’s drug development program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2017

Region: Global

Part of series: Program websites

This website about PATH’s Ethiopia country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2017

Region: Africa

Part of series: Program websites

The Making Malaria History newsletter is a periodic update on activities of the Malaria Control and Evaluation Partnership in Africa, which works to rapidly scale up proven malaria control interventions to achieve impact on health and economic indicators. Distributed three times per year, the newsletter includes updates on emerging malaria control insights, as well as perspectives from Zambia and our regional and global partners.

Publication date: 2017

Region: Africa

Part of series: E-newsletters

This website features updates on the latest malaria research and news, resources for advocates and technical partners, evidence and progress from the global malaria community, and field tools currently being used by countries at the forefront of the fight against the disease.

Publication date: 2017

Region: Africa

Part of series: Websites

This website about PATH’s Malaria Control and Evaluation Partnership in Africa (MACEPA) global program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2017

Region: Global

Part of series: Program websites

Launched in 2002, this website provides information on the Malaria Vaccine Initiative at PATH.

Publication date: 2017

Region: Global

Part of series: Websites

This website about PATH’s Tanzania country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2017

Region: Africa

Part of series: Program websites

This website about PATH’s Zambia country program provides an overview of the program and its featured projects. See other PATH program websites.

Publication date: 2017

Region: Africa

Part of series: Program websites

This poster demonstrates that the use of DHAp for malaria treatment was generally safe and well tolerated. A total of 687 adverse events (AEs) were reported (0.13% of participants, 0.24% of treatments). Four AEs were initially reported as serious adverse events, though three were later identified as not related to drug ingestion.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

This poster describes the key factors that led to El Salvador’s divergence from the malaria trajectory of its neighbors—Guatemala and Honduras—in the 1980s.

Publication date: November 2016

Region: Latin America

Part of series: ASTMH posters

The objective of the study was to evaluate whether case investigation with focal testing and focal drug administration can decrease malaria incidence. The lack of impact attributable to the program may have been due to the large increase in cases and subsequent imperfect case investigation, with 33% of eligible cases not investigated.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

This poster, which focuses on data from Ethiopia and Senegal, shows that differences between DHIS2 and the facility source records are small and decreased from 2013 to 2014, suggesting that the system can provide accurate and timely information on malaria transmission intensity at the health-post level.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

This poster details a study evaluating the cost-effectiveness of indoor residual spraying (IRS) with pirimiphos-methyl, in addition to long-lasting insecticide-treated bednets (LLINs) in an area of high malaria transmission and emerging pyrethroid resistance.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

Real-time, accurate, and actionable data are critical for malaria elimination; using dashboards to visualize malaria data in Zambia is one possible solution to strengthen feedback loops to the most granular levels and motivate end users. To make dashboards matter, dashboards should be developed jointly with eventual end users and focus on tools for practical decision-making.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters

This study aimed to monitor vector behavior, species composition, and vector susceptibility to insecticides used for malaria vector control to guide the malaria elimination agenda. Outdoor biting, early biting, pyrethroid insecticide resistance, and carbamate insecticide resistance were identified and could undermine elimination efforts. Additional interventions and sustainable insecticide resistance management strategies are likely to be required.

Publication date: November 2016

Region: Africa

Part of series: ASTMH posters